Public Policy

Can Medicare Advantage Reform Protect Seniors and Funds?
Public Policy Can Medicare Advantage Reform Protect Seniors and Funds?

Understanding Medicare Advantage and Traditional Medicare: An Overview The Medicare system, a cornerstone of healthcare for millions of American seniors, stands at a critical juncture as enrollment in Medicare Advantage (MA) plans continues to surge, reshaping how older adults access care. With

Physician-Owned Hospitals Spark Heated Healthcare Debate
Public Policy Physician-Owned Hospitals Spark Heated Healthcare Debate

The landscape of American healthcare stands at a critical crossroads as the debate over physician-owned hospitals (POHs) intensifies, carrying profound implications for access, equity, and financial stability across the sector. With over 150 rural hospitals closed since 2010 and many more on the

Modular Medical Submits Pivot Insulin Pump for FDA Clearance
Public Policy Modular Medical Submits Pivot Insulin Pump for FDA Clearance

Introduction to Diabetes Care Innovations In a world where over 38 million Americans live with diabetes, the quest for effective, user-friendly management tools has never been more critical, especially as the burden of daily insulin injections and complex treatment regimens often deters patients

How Will New Public Charge Rules Impact Immigrant Families?
Public Policy How Will New Public Charge Rules Impact Immigrant Families?

Overview of a Shifting Landscape In 2025, the landscape of U.S. immigration policy stands at a critical juncture, with proposed changes to public charge rules under the Trump administration sparking intense debate across communities and industries. A staggering statistic from the 2025 KFF/New York

Republicans Clash Over ACA Subsidy Extension Before 2026
Public Policy Republicans Clash Over ACA Subsidy Extension Before 2026

Setting the Stage: A Looming Health Insurance Cost Crisis As the enhanced Affordable Care Act (ACA) premium subsidies teeter on the brink of expiration in less than six weeks, a staggering 22 million Americans face the specter of skyrocketing health insurance costs, creating a critical juncture in

FDA's Biosimilar Boost Faces Patent Office Roadblocks
Public Policy FDA's Biosimilar Boost Faces Patent Office Roadblocks

Today, we’re diving into the complex world of biosimilar drugs and regulatory challenges with Faisal Zain, a renowned healthcare expert specializing in medical technology. With his extensive background in the manufacturing of medical devices for diagnostics and treatment, Faisal brings a unique p

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later